COCRYSTAL PHARMA, INC. Increase (Decrease) in Deferred Income Taxes
COCRYSTAL PHARMA, INC. (COCP) reported Increase (Decrease) in Deferred Income Taxes of $1.46 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2018-11-09
- COCRYSTAL PHARMA, INC. increase (decrease) in deferred income taxes for the quarter ending 2018-09-30 was $486.00K.
- COCRYSTAL PHARMA, INC. increase (decrease) in deferred income taxes for the quarter ending 2018-06-30 was $554.00K.
- COCRYSTAL PHARMA, INC. increase (decrease) in deferred income taxes for the quarter ending 2018-03-31 was $419.00K.
| Period end | Increase (Decrease) in Deferred Income Taxes 3 month | Increase (Decrease) in Deferred Income Taxes 6 month | Increase (Decrease) in Deferred Income Taxes 9 month |
|---|---|---|---|
| 2018-09-30 | $486.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $1.04M derived: sum of 2 quarters · filed 2018-11-09 | $1.46M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $554.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $973.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $419.00K 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |